Community Research and Development Information Service - CORDIS


Final Report - MED EPHV (Learning and practicing pharmacovigilance in the Mediterranean countries of the EU)

Project ID: 33016
Funded under: FP6-SME


The recognition and notification of adverse drug reactions (ADRs) is a complex task requiring knowledge and expertise from health professionals. The complexity of ADRs recognition and notification is at the origin of the current poor delivery of notifications, in terms of both quality and quantity, to the central medicines authorities (national and European agencies).

The MED EPHV project was intended to research and develop an innovative approach to the EU pharmacovigilance practice by designing and implementing a pharmacovigilance cooperative e-learning system specifically addressing the needs and profile of health practitioners and patients of Southern Europe (Mediterranean countries).

The scope of this final activity report is to present in a concise way the most important aspects of the MED EPHV project, and of the results achieved. More details can be found in the interim report covering the activities of the first year of the project and in the activity report for the second reporting period (from month 13 to month 28), that describes all activities, results achieved and planned actions for the future. More detailed information is included in the 27 contractual deliverables, which have been duly submitted to the European Commission.

Download application/pdf (5139411)

Related information

Record Number: 11411 / Last updated on: 2011-04-14
Category: PROJ